FDA Approves DIGOXIN — Amneal Pharmaceuticals of New York LLC

# FDA Approves Digoxin Generic from Amneal Pharmaceuticals Amneal Pharmaceuticals of New York LLC received FDA approval for its generic digoxin oral formulation, expanding treatment options in the competitive cardiac glycoside market and potentially increasing cost-effective alternatives for patients managing heart failure and atrial fibrillation. The approval of the ANDA application is expected to intensify price competition in the digoxin segment as additional generic manufacturers enter the market.